CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Seres Therapeutics Inc Company Snapshot
Seres Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Seres Therapeutics Inc with three other companies in this sector in the United States: Affimed NV (2018 sales of $27.97 million of which 93% was Collaboration revenue), GW Pharmaceuticals PLC ($26.62 million of which 100% was Novel Therapeutics), and Verastem Inc ($26.72 million of which 100% was Pharmaceuticals preparation).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Seres Therapeutics Inc
  Stock Performance Chart for Seres Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 3.69
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks 19.8%  
4 Weeks 37.2%   52 Weeks -56.1%  
 
Seres Therapeutics Inc Key Data:
  Ticker: MCRB Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 28,267,000
(Year Ending Jan 2019).
Employees: 145
  Currency: U.S. Dollars Market Cap: 258,277,683
  Fiscal Yr Ends: December Shares Outstanding: 69,993,952
  Share Type: Ordinary Closely Held Shares: 7,181,294
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.